vs
FATE THERAPEUTICS INC（FATE）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是FATE THERAPEUTICS INC的1.4倍（$1.9M vs $1.4M），Rigetti Computing, Inc.同比增速更快（-17.9% vs -26.4%），Rigetti Computing, Inc.自由现金流更多（$-19.5M vs $-112.0M），过去两年FATE THERAPEUTICS INC的营收复合增速更高（-15.7% vs -21.8%）
因西斯治疗是1990年成立、总部位于亚利桑那州钱德勒的美国特色制药企业，核心产品Subsys是芬太尼的舌下含服液体制剂。芬太尼是一种见效极快的强效阿片类药物，用于缓解癌症患者爆发性疼痛，在美国，用于该适应症的芬太尼处方通常要求已有记录证明保守疗法无效。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
FATE vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.4倍
$1.4M
营收增速更快
RGTI
高出8.5%
-26.4%
自由现金流更多
RGTI
多$92.6M
$-112.0M
两年增速更快
FATE
近两年复合增速
-21.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4M | $1.9M |
| 净利润 | — | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | — | -1209.7% |
| 净利率 | — | -974.7% |
| 营收同比 | -26.4% | -17.9% |
| 净利润同比 | 37.9% | 88.1% |
| 每股收益（稀释后） | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FATERGTI
| Q4 25 | $1.4M | $1.9M | ||
| Q3 25 | $1.7M | $1.9M | ||
| Q2 25 | $1.9M | $1.8M | ||
| Q1 25 | $1.6M | $1.5M | ||
| Q4 24 | $1.9M | $2.3M | ||
| Q3 24 | $3.1M | $2.4M | ||
| Q2 24 | $6.8M | $3.1M | ||
| Q1 24 | $1.9M | $3.1M |
净利润FATERGTI
| Q4 25 | — | $-18.2M | ||
| Q3 25 | $-32.3M | $-201.0M | ||
| Q2 25 | $-34.1M | $-39.7M | ||
| Q1 25 | $-37.6M | $42.6M | ||
| Q4 24 | — | $-153.0M | ||
| Q3 24 | $-47.7M | $-14.8M | ||
| Q2 24 | $-38.4M | $-12.4M | ||
| Q1 24 | $-48.0M | $-20.8M |
毛利率FATERGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率FATERGTI
| Q4 25 | — | -1209.7% | ||
| Q3 25 | -1995.1% | -1055.4% | ||
| Q2 25 | -1938.5% | -1103.9% | ||
| Q1 25 | -2534.1% | -1469.6% | ||
| Q4 24 | — | -813.3% | ||
| Q3 24 | -1703.9% | -729.4% | ||
| Q2 24 | -665.7% | -521.2% | ||
| Q1 24 | -2652.9% | -543.4% |
净利率FATERGTI
| Q4 25 | — | -974.7% | ||
| Q3 25 | -1852.4% | -10321.9% | ||
| Q2 25 | -1786.6% | -2201.8% | ||
| Q1 25 | -2309.5% | 2895.3% | ||
| Q4 24 | — | -6726.5% | ||
| Q3 24 | -1551.0% | -623.8% | ||
| Q2 24 | -567.4% | -402.5% | ||
| Q1 24 | -2493.7% | -680.6% |
每股收益（稀释后）FATERGTI
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.27 | $-0.62 | ||
| Q2 25 | $-0.29 | $-0.13 | ||
| Q1 25 | $-0.32 | $0.13 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $-0.40 | $-0.08 | ||
| Q2 24 | $-0.33 | $-0.07 | ||
| Q1 24 | $-0.47 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $203.7M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $207.2M | $546.2M |
| 总资产 | $318.9M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FATERGTI
| Q4 25 | $203.7M | $44.9M | ||
| Q3 25 | $215.4M | $26.1M | ||
| Q2 25 | $222.8M | $57.2M | ||
| Q1 25 | $240.4M | $37.2M | ||
| Q4 24 | $279.1M | $67.7M | ||
| Q3 24 | $296.9M | $20.3M | ||
| Q2 24 | $304.9M | $20.7M | ||
| Q1 24 | $121.3M | $35.1M |
股东权益FATERGTI
| Q4 25 | $207.2M | $546.2M | ||
| Q3 25 | $234.1M | $371.8M | ||
| Q2 25 | $261.4M | $553.3M | ||
| Q1 25 | $288.4M | $207.1M | ||
| Q4 24 | $318.7M | $126.6M | ||
| Q3 24 | $362.3M | $122.8M | ||
| Q2 24 | $397.0M | $122.2M | ||
| Q1 24 | $426.1M | $115.6M |
总资产FATERGTI
| Q4 25 | $318.9M | $666.6M | ||
| Q3 25 | $343.7M | $630.3M | ||
| Q2 25 | $371.6M | $636.7M | ||
| Q1 25 | $398.7M | $269.1M | ||
| Q4 24 | $440.7M | $284.8M | ||
| Q3 24 | $495.0M | $157.3M | ||
| Q2 24 | $528.8M | $162.4M | ||
| Q1 24 | $569.9M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-106.1M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | $-112.0M | $-19.5M |
| 自由现金流率自由现金流/营收 | -8183.9% | -1042.5% |
| 资本支出强度资本支出/营收 | 434.8% | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-199.6M | $-77.2M |
8季度趋势，按日历期对齐
经营现金流FATERGTI
| Q4 25 | $-106.1M | $-14.9M | ||
| Q3 25 | $-24.4M | $-13.8M | ||
| Q2 25 | $-24.6M | $-16.2M | ||
| Q1 25 | $-33.8M | $-13.7M | ||
| Q4 24 | $-122.9M | $-8.5M | ||
| Q3 24 | $-29.4M | $-15.4M | ||
| Q2 24 | $-32.3M | $-13.5M | ||
| Q1 24 | $-33.4M | $-13.1M |
自由现金流FATERGTI
| Q4 25 | $-112.0M | $-19.5M | ||
| Q3 25 | $-26.6M | $-19.7M | ||
| Q2 25 | $-25.9M | $-21.8M | ||
| Q1 25 | $-35.0M | $-16.2M | ||
| Q4 24 | $-123.6M | $-9.8M | ||
| Q3 24 | $-29.9M | $-17.7M | ||
| Q2 24 | $-32.4M | $-15.6M | ||
| Q1 24 | $-33.4M | $-18.6M |
自由现金流率FATERGTI
| Q4 25 | -8183.9% | -1042.5% | ||
| Q3 25 | -1526.5% | -1012.4% | ||
| Q2 25 | -1360.7% | -1212.4% | ||
| Q1 25 | -2148.9% | -1100.4% | ||
| Q4 24 | -6645.4% | -432.1% | ||
| Q3 24 | -973.1% | -744.5% | ||
| Q2 24 | -477.8% | -504.3% | ||
| Q1 24 | -1736.9% | -610.5% |
资本支出强度FATERGTI
| Q4 25 | 434.8% | 244.8% | ||
| Q3 25 | 126.5% | 302.5% | ||
| Q2 25 | 71.4% | 314.7% | ||
| Q1 25 | 73.4% | 173.0% | ||
| Q4 24 | 39.2% | 56.4% | ||
| Q3 24 | 16.1% | 95.8% | ||
| Q2 24 | 0.8% | 66.3% | ||
| Q1 24 | 4.5% | 180.0% |
现金转化率FATERGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FATE
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
